NCT02829723 2024-01-18A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid TumorsNovartisPhase 1/2 Terminated192 enrolled 77 charts
NCT03707457 2020-07-02Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of GlioblastomaSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 Terminated3 enrolled